Citigroup »

4d Molecular Therapeutics In shares owned by Citigroup

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $847k 41k 20.50
2023-09-30 $696k 55k 12.73
2023-03-31 $1.9M 112k 17.19
2022-12-31 $573k 26k 22.21
2022-09-30 $80k 9.9k 8.09
2021-12-31 $1.8M 83k 21.94
2021-03-31 $59k 1.4k 43.13